Details of the Drug

General Information of Drug (ID: DM00ACQ)

Drug Name

ABP 938

Synonyms

aflibercept biosimilar

Indication

Disease Entry	ICD 11	Status	REF
Neovascular age-related macular degeneration	9B78.3Z	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Fusion protein

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Vascular endothelial growth factor receptor (VEGFR)	TTVJ1D8	NOUNIPROTAC	Not Available	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT04270747) A Randomized, Double-masked, Phase 3 Study of ABP 938 Efficacy and Safety Compared to Aflibercept (Eylea?) in Subjects With Neovascular Age-related Macular Degeneration. U.S.National Institutes of Health.
2	Clinical pipeline report, company report or official report of Amgen